Phase II trial of bevacizumab + cetuximab + cisplatin with concurrent intensity-modulated radiation therapy for patients with stage III/IVB head and neck squamous cell carcinoma
2014 ◽
Vol 90
(1)
◽
pp. S535
2020 ◽
Vol 106
(3)
◽
pp. 564-570
◽
2013 ◽
Vol 87
(2)
◽
pp. S469
2011 ◽
Vol 81
(2)
◽
pp. S545
2009 ◽
Vol 75
(3)
◽
pp. S386-S387
2010 ◽
Vol 78
(3)
◽
pp. S465
2013 ◽
Vol 87
(2)
◽
pp. S468-S469